Far East Orchard Limited Stocks

SGD 1.16Last Updated 08.04.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

SGD 439.33M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SGD 1.16
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Decent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Far East Orchard Limited, an investment holding company, engages in the hotel operations and property investment activities in Singapore, Australia, New Zealand, the United Kingdom, and internationally. The company primarily develops residential, commercial, hospitality, and purpose-built student accommodation properties. It also owns and operates hospitality assets, including hotels. In addition, the company's investment portfolio includes offices at Tanglin Shopping Centre, as well as medical suites at Novena Medical Center and Novena Specialist Center. Further, it manages and leases properties. The company was formerly known as Orchard Parade Holdings Limited and changed its name to Far East Orchard Limited in July 2012. The company was incorporated in 1967 and is headquartered in Singapore. Far East Orchard Limited is a subsidiary of Far East Organization Pte. Ltd.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, overvalued on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks